Management Team

Vitae Pharmaceuticals’ leadership team has had significant experience discovering, developing and commercializing highly successful drugs in multiple therapeutic areas for both large and small pharmaceutical companies. In addition, Vitae Pharmaceuticals’ business and R&D teams are supported by a group of investors and advisors with significant expertise in developing pharmaceutical enterprises and enhancing their impact, capabilities and results.

Jeffrey S. Hatfield
President & Chief Executive Officer

Richard Gregg, M.D.
Chief Scientific Officer

Richard Morris
Chief Financial Officer

Arthur Fratamico, R.Ph.
Chief Business Officer

David A. Claremon, Ph.D.
Vice President, Chemistry

Gerard M. McGeehan, Ph.D.
Vice President, Discovery Biology